Waybrun Hebert, DPM
Foot & Ankle Surgery · Houma, LANPI 1336133008
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Crossroads Extremity Systems, LLC at 52.9% of the total. Reporting peaked in 2019 at $924 and has fallen 97.0% since, to $27 in 2024. That places this record below the midpoint for foot & ankle surgery clinicians in LA, where the typical reported total is $2,260.
Across 33 payments — averaging $38.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Crossroads Extremity Systems, LLC$674
- Smith+Nephew$180
- Boston Scientific$86
- Paratek Pharmaceuticals, Inc.$72
- Organogenesis Inc.$63
- GRT US Holding, Inc.$48
- plus $151 from 6 others
What the payments were for
- Food & beverage$1,275100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Crossroads Extremity Systems, LLC | 6 | $674 |
| Smith+Nephew | 11 | $180 |
| Boston Scientific | 1 | $86 |
| Paratek Pharmaceuticals, Inc. | 4 | $72 |
| Organogenesis Inc. | 2 | $63 |
| GRT US Holding, Inc. | 2 | $48 |
| Zyla Life Sciences, Inc. | 2 | $31 |
| Stryker | 1 | $30 |
| Medtronic | 1 | $29 |
| KCI USA, Inc. | 1 | $25 |
| Bioventus LLC | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
How this compares
$1,275 in reported general payments places this provider in the 40th percentile of 92 foot & ankle surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine-PrilocaineLidocaine/Prilocaine | 28 | $1,799 |
| Terbinafine Hcl | 30 | $660 |
| Diclofenac Sodium | 11 | $638 |
| Ketoconazole | 20 | $289 |
| Mupirocin | 21 | $202 |
| Allopurinol | 30 | $189 |
| Methylprednisolone | 13 | $96 |
| Cephalexin | 13 | $42 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Houma
- Brian BensonLeesville$278K
- Meredith WarnerBaton Rouge$232K
- Tyson GreenLake Charles$203K
- Bryon McKennaThibodaux$131K
- Mohamad IssaNew Orleans$24K
- Leon WatkinsMetairie$18K
- Phuoc BuiMinden$15K
- Henrique HilarioShreveport$14K
- Beau WillisMetairie$13K
- Nimish ChokshiMetairie$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.